Market Access/ News/ News FDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilar Phil Taylor biosimilar, fda, interchangeable, Lantus, Mylan, Sanofi, US 0 Comment Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is Share X FDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilar https://pharmaphorum.com/news/fda-okays-mylan-insulin-drug-as-first-interchangeable-biosimilar/